These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9919310)

  • 21. Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours.
    Horan MP; Cooper DN; Upadhyaya M
    Hum Genet; 2000 Jul; 107(1):33-9. PubMed ID: 10982032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
    Kluwe L; Friedrich RE; Mautner VF
    Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of neurofibromatosis type 1 using RFLPs tightly linked to gene.
    Vivarelli R; Bartalani G; Berardi A; Calistri L; Balestri P; Fois A
    Childs Nerv Syst; 1993 Jun; 9(3):147-9. PubMed ID: 8104099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect.
    Takano T; Kawashima T; Yamanouchi Y; Kitayama K; Baba T; Ueno K; Hamaguchi H
    Hum Genet; 1992 May; 89(3):281-6. PubMed ID: 1351032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers.
    Oğuzkan S; Cinbiş M; Ayter S; Anlar B; Aysun S
    Turk J Pediatr; 2003; 45(3):192-7. PubMed ID: 14696795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
    Nakafuku M; Nagamine M; Ohtoshi A; Tanaka K; Toh-e A; Kaziro Y
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6706-10. PubMed ID: 8341688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene.
    Perrin G; Morris MA; Antonarakis SE; Boltshauser E; Hutter P
    Hum Mutat; 1996; 7(2):172-5. PubMed ID: 8829638
    [No Abstract]   [Full Text] [Related]  

  • 32. The hunt for the neurofibromatosis gene.
    Goldberg NS; Collins FS
    Arch Dermatol; 1991 Nov; 127(11):1705-7. PubMed ID: 1952978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis: from gene to phenotype.
    Ponder BA
    Semin Cancer Biol; 1992 Jun; 3(3):115-20. PubMed ID: 1511154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
    Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
    Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of sporadic and inherited mutations in exon 31 of the neurofibromatosis (NF1) gene.
    Ainsworth PJ; Rodenhiser DI; Costa MT
    Hum Genet; 1993 Mar; 91(2):151-6. PubMed ID: 8385067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17q inversion involving the neurofibromatosis type one locus in a family with neurofibromatosis type one.
    Asamoah A; North K; Doran S; Wagstaff J; Ogle R; Collins FS; Korf BR
    Am J Med Genet; 1995 Aug; 60(4):312-6. PubMed ID: 7485267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata.
    Leppig KA; Kaplan P; Viskochil D; Weaver M; Ortenberg J; Stephens K
    Am J Med Genet; 1997 Dec; 73(2):197-204. PubMed ID: 9409873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
    Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
    Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.
    Ars E; Serra E; García J; Kruyer H; Gaona A; Lázaro C; Estivill X
    Hum Mol Genet; 2000 Jan; 9(2):237-47. PubMed ID: 10607834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.